tradingkey.logo
搜尋

Myomo Inc

MYO
添加自選
1.189USD
+0.129+12.14%
交易中 美東報價延遲15分鐘
45.84M總市值
虧損本益比TTM

關於 Myomo Inc 公司

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc簡介

公司代碼MYO
公司名稱Myomo Inc
上市日期Jun 12, 2017
CEOGudonis (Paul R)
員工數量184
證券類型Ordinary Share
年結日Jun 12
公司地址137 Portland Street
城市BOSTON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編02114
電話16179969058
網址https://myomo.com/
公司代碼MYO
上市日期Jun 12, 2017
CEOGudonis (Paul R)

Myomo Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.37M
+0.77%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
465.03K
+0.58%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.37M
+0.77%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
465.03K
+0.58%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--

常見問題

Myomo Inc的前五大股東是誰?

Myomo Inc的前五大股東如下:Mr. Paul R. Gudonis

有多少機構持有Myomo Inc(MYO)的股份?

截至2026Q1,共有185家機構持有Myomo Inc的股份,合計持有的股份價值約為23.44M,占公司總股份的63.19% 。與2025Q4相比,機構持股有所增加,增幅為-5843597.00。

哪個業務部門對Myomo Inc的收入貢獻最大?

在2026Q1,Direct to patient業務部門對Myomo Inc的收入貢獻最大,創收7.32M,占總收入的72.56% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有